nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinapril—Mediastinal disorder—Vandetanib—thyroid cancer	0.00756	0.00756	CcSEcCtD
Quinapril—Arrhythmia—Vandetanib—thyroid cancer	0.00749	0.00749	CcSEcCtD
Quinapril—Alopecia—Vandetanib—thyroid cancer	0.00741	0.00741	CcSEcCtD
Quinapril—Breast disorder—Sorafenib—thyroid cancer	0.00739	0.00739	CcSEcCtD
Quinapril—Mental disorder—Vandetanib—thyroid cancer	0.00735	0.00735	CcSEcCtD
Quinapril—Pancreatitis—Sorafenib—thyroid cancer	0.00693	0.00693	CcSEcCtD
Quinapril—Erectile dysfunction—Sorafenib—thyroid cancer	0.00651	0.00651	CcSEcCtD
Quinapril—Loss of consciousness—Vandetanib—thyroid cancer	0.00642	0.00642	CcSEcCtD
Quinapril—Cough—Vandetanib—thyroid cancer	0.00637	0.00637	CcSEcCtD
Quinapril—Infestation NOS—Sorafenib—thyroid cancer	0.0063	0.0063	CcSEcCtD
Quinapril—Infestation—Sorafenib—thyroid cancer	0.0063	0.0063	CcSEcCtD
Quinapril—Chest pain—Vandetanib—thyroid cancer	0.00622	0.00622	CcSEcCtD
Quinapril—Arthralgia—Vandetanib—thyroid cancer	0.00622	0.00622	CcSEcCtD
Quinapril—Acute coronary syndrome—Sorafenib—thyroid cancer	0.00621	0.00621	CcSEcCtD
Quinapril—Renal failure—Sorafenib—thyroid cancer	0.0062	0.0062	CcSEcCtD
Quinapril—Myocardial infarction—Sorafenib—thyroid cancer	0.00618	0.00618	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.00617	0.00617	CcSEcCtD
Quinapril—Dry mouth—Vandetanib—thyroid cancer	0.00608	0.00608	CcSEcCtD
Quinapril—Hepatobiliary disease—Sorafenib—thyroid cancer	0.00596	0.00596	CcSEcCtD
Quinapril—Oedema—Vandetanib—thyroid cancer	0.00596	0.00596	CcSEcCtD
Quinapril—Infection—Vandetanib—thyroid cancer	0.00592	0.00592	CcSEcCtD
Quinapril—Nervous system disorder—Vandetanib—thyroid cancer	0.00584	0.00584	CcSEcCtD
Quinapril—Thrombocytopenia—Vandetanib—thyroid cancer	0.00584	0.00584	CcSEcCtD
Quinapril—Skin disorder—Vandetanib—thyroid cancer	0.00579	0.00579	CcSEcCtD
Quinapril—Urinary tract disorder—Sorafenib—thyroid cancer	0.00559	0.00559	CcSEcCtD
Quinapril—Connective tissue disorder—Sorafenib—thyroid cancer	0.00556	0.00556	CcSEcCtD
Quinapril—Urethral disorder—Sorafenib—thyroid cancer	0.00555	0.00555	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00543	0.00543	CcSEcCtD
Quinapril—Amblyopia—Epirubicin—thyroid cancer	0.00539	0.00539	CcSEcCtD
Quinapril—Insomnia—Vandetanib—thyroid cancer	0.00539	0.00539	CcSEcCtD
Quinapril—Paraesthesia—Vandetanib—thyroid cancer	0.00535	0.00535	CcSEcCtD
Quinapril—Dyspnoea—Vandetanib—thyroid cancer	0.00531	0.00531	CcSEcCtD
Quinapril—Cardiac disorder—Sorafenib—thyroid cancer	0.00525	0.00525	CcSEcCtD
Quinapril—Dyspepsia—Vandetanib—thyroid cancer	0.00525	0.00525	CcSEcCtD
Quinapril—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00515	0.00515	CcSEcCtD
Quinapril—Fatigue—Vandetanib—thyroid cancer	0.00514	0.00514	CcSEcCtD
Quinapril—Angiopathy—Sorafenib—thyroid cancer	0.00513	0.00513	CcSEcCtD
Quinapril—Immune system disorder—Sorafenib—thyroid cancer	0.00511	0.00511	CcSEcCtD
Quinapril—Mediastinal disorder—Sorafenib—thyroid cancer	0.0051	0.0051	CcSEcCtD
Quinapril—Constipation—Vandetanib—thyroid cancer	0.0051	0.0051	CcSEcCtD
Quinapril—Arrhythmia—Sorafenib—thyroid cancer	0.00505	0.00505	CcSEcCtD
Quinapril—Alopecia—Sorafenib—thyroid cancer	0.005	0.005	CcSEcCtD
Quinapril—Amblyopia—Doxorubicin—thyroid cancer	0.00499	0.00499	CcSEcCtD
Quinapril—Mental disorder—Sorafenib—thyroid cancer	0.00496	0.00496	CcSEcCtD
Quinapril—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00487	0.00487	CcSEcCtD
Quinapril—Vasodilation—Epirubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Quinapril—Vasodilation procedure—Epirubicin—thyroid cancer	0.00474	0.00474	CcSEcCtD
Quinapril—Abdominal pain—Vandetanib—thyroid cancer	0.00471	0.00471	CcSEcCtD
Quinapril—Viral infection—Epirubicin—thyroid cancer	0.00461	0.00461	CcSEcCtD
Quinapril—Angioedema—Sorafenib—thyroid cancer	0.0045	0.0045	CcSEcCtD
Quinapril—Syncope—Sorafenib—thyroid cancer	0.00442	0.00442	CcSEcCtD
Quinapril—Vasodilation—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Quinapril—Vasodilation procedure—Doxorubicin—thyroid cancer	0.00439	0.00439	CcSEcCtD
Quinapril—Loss of consciousness—Sorafenib—thyroid cancer	0.00433	0.00433	CcSEcCtD
Quinapril—Cough—Sorafenib—thyroid cancer	0.0043	0.0043	CcSEcCtD
Quinapril—Asthenia—Vandetanib—thyroid cancer	0.00428	0.00428	CcSEcCtD
Quinapril—Viral infection—Doxorubicin—thyroid cancer	0.00427	0.00427	CcSEcCtD
Quinapril—Pruritus—Vandetanib—thyroid cancer	0.00422	0.00422	CcSEcCtD
Quinapril—Arthralgia—Sorafenib—thyroid cancer	0.00419	0.00419	CcSEcCtD
Quinapril—Myalgia—Sorafenib—thyroid cancer	0.00419	0.00419	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00416	0.00416	CcSEcCtD
Quinapril—Dry mouth—Sorafenib—thyroid cancer	0.0041	0.0041	CcSEcCtD
Quinapril—Hyperkalaemia—Epirubicin—thyroid cancer	0.00409	0.00409	CcSEcCtD
Quinapril—Diarrhoea—Vandetanib—thyroid cancer	0.00408	0.00408	CcSEcCtD
Quinapril—Anaphylactic shock—Sorafenib—thyroid cancer	0.00402	0.00402	CcSEcCtD
Quinapril—Infection—Sorafenib—thyroid cancer	0.00399	0.00399	CcSEcCtD
Quinapril—Shock—Sorafenib—thyroid cancer	0.00396	0.00396	CcSEcCtD
Quinapril—Nervous system disorder—Sorafenib—thyroid cancer	0.00394	0.00394	CcSEcCtD
Quinapril—Dizziness—Vandetanib—thyroid cancer	0.00394	0.00394	CcSEcCtD
Quinapril—Thrombocytopenia—Sorafenib—thyroid cancer	0.00394	0.00394	CcSEcCtD
Quinapril—Blood urea increased—Epirubicin—thyroid cancer	0.00393	0.00393	CcSEcCtD
Quinapril—Skin disorder—Sorafenib—thyroid cancer	0.0039	0.0039	CcSEcCtD
Quinapril—Vomiting—Vandetanib—thyroid cancer	0.00379	0.00379	CcSEcCtD
Quinapril—Hyperkalaemia—Doxorubicin—thyroid cancer	0.00379	0.00379	CcSEcCtD
Quinapril—Rash—Vandetanib—thyroid cancer	0.00376	0.00376	CcSEcCtD
Quinapril—Dermatitis—Vandetanib—thyroid cancer	0.00375	0.00375	CcSEcCtD
Quinapril—Headache—Vandetanib—thyroid cancer	0.00373	0.00373	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00366	0.00366	CcSEcCtD
Quinapril—Blood urea increased—Doxorubicin—thyroid cancer	0.00364	0.00364	CcSEcCtD
Quinapril—Dyspnoea—Sorafenib—thyroid cancer	0.00358	0.00358	CcSEcCtD
Quinapril—Nausea—Vandetanib—thyroid cancer	0.00354	0.00354	CcSEcCtD
Quinapril—Dyspepsia—Sorafenib—thyroid cancer	0.00354	0.00354	CcSEcCtD
Quinapril—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00347	0.00347	CcSEcCtD
Quinapril—Fatigue—Sorafenib—thyroid cancer	0.00347	0.00347	CcSEcCtD
Quinapril—Constipation—Sorafenib—thyroid cancer	0.00344	0.00344	CcSEcCtD
Quinapril—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00329	0.00329	CcSEcCtD
Quinapril—Renal failure acute—Epirubicin—thyroid cancer	0.00327	0.00327	CcSEcCtD
Quinapril—Dermatitis exfoliative—Epirubicin—thyroid cancer	0.0032	0.0032	CcSEcCtD
Quinapril—Abdominal pain—Sorafenib—thyroid cancer	0.00318	0.00318	CcSEcCtD
Quinapril—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00312	0.00312	CcSEcCtD
Quinapril—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00308	0.00308	CcSEcCtD
Quinapril—Renal failure acute—Doxorubicin—thyroid cancer	0.00303	0.00303	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00302	0.00302	CcSEcCtD
Quinapril—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00296	0.00296	CcSEcCtD
Quinapril—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00289	0.00289	CcSEcCtD
Quinapril—Asthenia—Sorafenib—thyroid cancer	0.00288	0.00288	CcSEcCtD
Quinapril—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00285	0.00285	CcSEcCtD
Quinapril—Pruritus—Sorafenib—thyroid cancer	0.00284	0.00284	CcSEcCtD
Quinapril—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.0028	0.0028	CcSEcCtD
Quinapril—Liver function test abnormal—Epirubicin—thyroid cancer	0.00279	0.00279	CcSEcCtD
Quinapril—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00276	0.00276	CcSEcCtD
Quinapril—Diarrhoea—Sorafenib—thyroid cancer	0.00275	0.00275	CcSEcCtD
Quinapril—Breast disorder—Epirubicin—thyroid cancer	0.00273	0.00273	CcSEcCtD
Quinapril—Dizziness—Sorafenib—thyroid cancer	0.00266	0.00266	CcSEcCtD
Quinapril—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00258	0.00258	CcSEcCtD
Quinapril—Pancreatitis—Epirubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Quinapril—Vomiting—Sorafenib—thyroid cancer	0.00256	0.00256	CcSEcCtD
Quinapril—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00255	0.00255	CcSEcCtD
Quinapril—Angina pectoris—Epirubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Quinapril—Rash—Sorafenib—thyroid cancer	0.00253	0.00253	CcSEcCtD
Quinapril—Dermatitis—Sorafenib—thyroid cancer	0.00253	0.00253	CcSEcCtD
Quinapril—Breast disorder—Doxorubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Quinapril—Headache—Sorafenib—thyroid cancer	0.00252	0.00252	CcSEcCtD
Quinapril—Nausea—Sorafenib—thyroid cancer	0.00239	0.00239	CcSEcCtD
Quinapril—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Quinapril—Pancreatitis—Doxorubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Quinapril—Angina pectoris—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Quinapril—Infestation NOS—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Quinapril—Infestation—Epirubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Quinapril—Renal failure—Epirubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Quinapril—Urinary tract infection—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Quinapril—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Quinapril—Hepatobiliary disease—Epirubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Quinapril—Agranulocytosis—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Quinapril—Infestation NOS—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Quinapril—Infestation—Doxorubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Quinapril—Renal failure—Doxorubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Quinapril—Urinary tract infection—Doxorubicin—thyroid cancer	0.0021	0.0021	CcSEcCtD
Quinapril—Hepatitis—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Quinapril—Pharyngitis—Epirubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Quinapril—Urinary tract disorder—Epirubicin—thyroid cancer	0.00207	0.00207	CcSEcCtD
Quinapril—Connective tissue disorder—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Quinapril—Urethral disorder—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Quinapril—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Quinapril—Agranulocytosis—Doxorubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Quinapril—Eye disorder—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Quinapril—Cardiac disorder—Epirubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Quinapril—Hepatitis—Doxorubicin—thyroid cancer	0.00193	0.00193	CcSEcCtD
Quinapril—Pharyngitis—Doxorubicin—thyroid cancer	0.00192	0.00192	CcSEcCtD
Quinapril—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Quinapril—Connective tissue disorder—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Quinapril—Angiopathy—Epirubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Quinapril—Urethral disorder—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Quinapril—Immune system disorder—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Quinapril—Mediastinal disorder—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Quinapril—Arrhythmia—Epirubicin—thyroid cancer	0.00187	0.00187	CcSEcCtD
Quinapril—Alopecia—Epirubicin—thyroid cancer	0.00185	0.00185	CcSEcCtD
Quinapril—Mental disorder—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Quinapril—Eye disorder—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Quinapril—Cardiac disorder—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Quinapril—Flatulence—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Quinapril—Tension—Epirubicin—thyroid cancer	0.00179	0.00179	CcSEcCtD
Quinapril—Nervousness—Epirubicin—thyroid cancer	0.00177	0.00177	CcSEcCtD
Quinapril—Back pain—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Quinapril—Angiopathy—Doxorubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Quinapril—Immune system disorder—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Quinapril—Mediastinal disorder—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Quinapril—Arrhythmia—Doxorubicin—thyroid cancer	0.00173	0.00173	CcSEcCtD
Quinapril—Alopecia—Doxorubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Quinapril—Mental disorder—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Quinapril—Ill-defined disorder—Epirubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Quinapril—Flatulence—Doxorubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Quinapril—Tension—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Quinapril—Malaise—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Quinapril—Nervousness—Doxorubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Quinapril—Vertigo—Epirubicin—thyroid cancer	0.00164	0.00164	CcSEcCtD
Quinapril—Syncope—Epirubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Quinapril—Back pain—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Quinapril—Palpitations—Epirubicin—thyroid cancer	0.00161	0.00161	CcSEcCtD
Quinapril—Loss of consciousness—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Quinapril—Cough—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Quinapril—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Quinapril—Arthralgia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Quinapril—Chest pain—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Quinapril—Myalgia—Epirubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Quinapril—Discomfort—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Quinapril—Malaise—Doxorubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Quinapril—Dry mouth—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Quinapril—Vertigo—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Quinapril—Syncope—Doxorubicin—thyroid cancer	0.00151	0.00151	CcSEcCtD
Quinapril—Palpitations—Doxorubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Quinapril—Oedema—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Quinapril—Anaphylactic shock—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Quinapril—Loss of consciousness—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Quinapril—Infection—Epirubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Quinapril—Cough—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Quinapril—Shock—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Quinapril—Nervous system disorder—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Quinapril—Thrombocytopenia—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Quinapril—Tachycardia—Epirubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Quinapril—Skin disorder—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Quinapril—Hyperhidrosis—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Quinapril—Arthralgia—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Quinapril—Chest pain—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Quinapril—Myalgia—Doxorubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Quinapril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Quinapril—Discomfort—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Quinapril—Dry mouth—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Quinapril—Oedema—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Quinapril—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Quinapril—Infection—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Quinapril—Shock—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Quinapril—Nervous system disorder—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Quinapril—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Quinapril—Insomnia—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Quinapril—Tachycardia—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Quinapril—Skin disorder—Doxorubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Quinapril—Paraesthesia—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Quinapril—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Quinapril—Dyspnoea—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Quinapril—Somnolence—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Quinapril—Dyspepsia—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Quinapril—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Quinapril—Fatigue—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Quinapril—Constipation—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Quinapril—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Quinapril—Insomnia—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Quinapril—Paraesthesia—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Quinapril—Dyspnoea—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Quinapril—Feeling abnormal—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Quinapril—Somnolence—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Quinapril—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Quinapril—Dyspepsia—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Quinapril—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Quinapril—Fatigue—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Quinapril—Constipation—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Quinapril—Abdominal pain—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Quinapril—Feeling abnormal—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Quinapril—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Quinapril—Abdominal pain—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Quinapril—Asthenia—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Quinapril—Pruritus—Epirubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Quinapril—Diarrhoea—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Quinapril—Asthenia—Doxorubicin—thyroid cancer	0.000986	0.000986	CcSEcCtD
Quinapril—Dizziness—Epirubicin—thyroid cancer	0.000982	0.000982	CcSEcCtD
Quinapril—Pruritus—Doxorubicin—thyroid cancer	0.000973	0.000973	CcSEcCtD
Quinapril—Vomiting—Epirubicin—thyroid cancer	0.000945	0.000945	CcSEcCtD
Quinapril—Diarrhoea—Doxorubicin—thyroid cancer	0.000941	0.000941	CcSEcCtD
Quinapril—Rash—Epirubicin—thyroid cancer	0.000937	0.000937	CcSEcCtD
Quinapril—Dermatitis—Epirubicin—thyroid cancer	0.000936	0.000936	CcSEcCtD
Quinapril—Headache—Epirubicin—thyroid cancer	0.000931	0.000931	CcSEcCtD
Quinapril—Dizziness—Doxorubicin—thyroid cancer	0.000909	0.000909	CcSEcCtD
Quinapril—Nausea—Epirubicin—thyroid cancer	0.000882	0.000882	CcSEcCtD
Quinapril—Vomiting—Doxorubicin—thyroid cancer	0.000874	0.000874	CcSEcCtD
Quinapril—Rash—Doxorubicin—thyroid cancer	0.000867	0.000867	CcSEcCtD
Quinapril—Dermatitis—Doxorubicin—thyroid cancer	0.000866	0.000866	CcSEcCtD
Quinapril—Headache—Doxorubicin—thyroid cancer	0.000861	0.000861	CcSEcCtD
Quinapril—Nausea—Doxorubicin—thyroid cancer	0.000817	0.000817	CcSEcCtD
